EMOTIONAL FACTORS IN PSORIASIS.
Ontology highlight
ABSTRACT:
SUBMITTER: Chaudhary S
PROVIDER: S-EPMC5530260 | biostudies-other | 1996 Jan
REPOSITORIES: biostudies-other
Similar Datasets
Project description:Anxiety and depression levels in 25 duodenal ulcer patients were compared with equal numbers of age and sex matched normal controls, hospitalised patients with nonpsychosomatic medical illnesses and inpatients with neurosis. Sinha's anxiety scale and Hamilton's rating scale for depression were used to measure the levels of anxiety and depression respectively. Patients with duodenal ulcer were significantly more anxious and depressed as compared to normal subjects and patients with medical illnesses. Duodenal ulcer patients were significantly less anxious and depressed as compared to neurotics. Therapeutic role of tricyclic antidepressants in management of duodenal ulcer is briefly discussed.
| S-EPMC5529673 | biostudies-other
Project description:The purpose of the study was to analyze the psychological and emotional determinants of domestic dissemination of information about genetic risk of cancer and to compare the level of diffusion syndromes in breast/ ovarian cancer ( BRCA1 / BRCA2) and colon/endometrial ( HNPCC )
| 2300891 | ecrin-mdr-crc
Project description:BackgroundSince the introduction of biologics for psoriasis, uptake has been uneven and limited. Few studies have investigated the influence of socioeconomic factors on access to biologics.ObjectiveTo investigate how socioeconomic factors influenced access to biologics.MethodsBiologic-naïve patients in the Swedish National Register for Systemic Treatment of Psoriasis (PsoReg) for the years 2006-2014 were included. For patients who remained on nonbiologic treatments during their entire registration (n = 1851), the most recent registration was analyzed. For patients who began treatment with biologics during registration in PsoReg (n = 665), the last observation before initiation of biologics was analyzed. A logistic regression model was used to investigate whether education and income influenced the probability of a switch to biologics, whilst adjusting for demographic and individual factors such as age, sex, disease severity, and clinical characteristics.ResultsThe odds ratio of access to biologics was 1.8 (CI = 1.3-2.6) in the group with a high level of disposable income, compared with the middle-income group. No differences were found concerning educational levels. The odds ratios of access to biologics decreased with age. Patients with psoriatic arthritis had odds ratios of access to biologics which were more than 50 percent higher, controlling for other variables. High disease severity, in terms of physician- and patient-reported severity, increased the odds ratios of access to biologics.ConclusionsThe higher-income group had better access to biologics than the middle-income group when adjusting for disease severity and lifestyle factors. This may not only be an equity problem, as a better allocation of society's resources might have resulted in a higher overall effectiveness of biologics.
| S-EPMC10707342 | biostudies-literature
Project description:Chronic orofacial pain: Genetics, cognitive-emotional factors, and endogenous modulatory systems
| PRJNA1003618 | ENA
Project description:BackgroundStudies assessing cardiovascular disease (CVD) risk factors in patients with psoriasis have been limited by selection bias, inappropriate controls or a reliance on data collected for clinical reasons.ObjectivesTo investigate whether screening for CVD risk factors in patients with psoriasis in primary care augments the known prevalence of CVD risk factors in a cross-sectional study.MethodsPatients listed as having psoriasis in primary care were recruited, screened and risk assessed by QRISK2.ResultsIn total, 287 patients attended (mean age 53 years, 57% women, 94% white British, 22% severe disease, 33% self-reported psoriatic arthritis). The proportion with known and screen-detected (previously unknown) risk factors was as follows: hypertension 35% known and 13% screen-detected; hypercholesterolaemia 32% and 37%; diabetes 6·6% and 3·1% and chronic kidney disease 1·1% and 4·5%. At least one screen-detected risk factor was found in 48% and two or more risk factors were found in 21% of patients. One in three patients (37%) not previously known to be at high risk were found to have a high (> 10%) 10-year CVD risk. Among the participants receiving treatment for known CVD risk factors, nearly half had suboptimal levels for blood pressure (46%) and cholesterol (46%).ConclusionsCardiovascular risk factor screening of primary care-based adults with psoriasis identified a high proportion of patients (i) at high CVD risk, (ii) with screen-detected risk factors and (iii) with suboptimally managed known risk factors. These findings need to be considered alongside reports that detected limited responses of clinicians to identified risk factors before universal CVD screening can be recommended.
| S-EPMC5113692 | biostudies-literature
Project description:Cardiovascular risk factors are one of the most common comorbidities in psoriasis. A higher prevalence of hypertension, insulin resistance and type 2 diabetes, dyslipidemia, obesity, metabolic syndrome, depression, as well as cardiovascular disease was confirmed in psoriatic patients in comparison to the general population. Data suggest that psoriasis and systemic inflammatory disorders may originate from the pleiotropic interactions with many genetic pathways. In this review, the authors present the current state of knowledge on the potential genetic links between psoriasis and cardiovascular risk factors. The understanding of the processes linking psoriasis with cardiovascular risk factors can lead to improvement of psoriasis management in the future.
| S-EPMC8396451 | biostudies-literature
Project description:Psoriasis is a common chronic inflammatory skin disease with a spectrum of clinical phenotypes and results from the interplay of genetic, environmental, and immunological factors. Four decades of clinical and basic research on psoriasis have elucidated many of the pathogenic mechanisms underlying disease and paved the way to effective targeted therapies. Here, we review this progress and identify future directions of study that are supported by a more integrative research approach and aim at further improving the patients' life.
| S-EPMC4109580 | biostudies-other
Project description:Early identification and intervention have been recommended for newly diagnosed prostate cancer patients who experience significant emotional distress; however, there is little empirical basis for designing or selecting interventions for these men. We sought to identify factors that are associated with distress in these men as a basis for identifying suitable intervention strategies.Using cross-sectional data and validated scales, we investigated the extent to which clinical, demographic, belief, and personality characteristics are associated with emotional distress assessed with the Distress Thermometer in 1425 men newly diagnosed with clinically localized prostate cancer (pretreatment).Beliefs potentially amenable to psychoeducational interventions [low self-efficacy for decision-making (B?=-0.11, p?=?0.02), low confidence in cancer control (B?=-0.03, p?<?0.001), and masculine identity threat (B?=-0.26, p?=?0.001)] were associated with higher emotional distress, as well as personality factors [low optimism (B?=-0.04, p?=?0.052) and low resilience (B?=-0.83, p?<?0.001)].Findings provide a framework for the development of interventions for prostate cancer patients with elevated emotional distress. These may include improving provider communication about prostate cancer prognosis for those with low confidence in cancer control, providing decision-making support to increase decision-making self-efficacy, or referral to brief cognitive behavioral interventions to help patients reframe masculine identity threat or for those with low optimism or resilience reframe and adjust to the health threat.
| S-EPMC5549449 | biostudies-literature
Project description:Categorical perception (CP), the perceptual experience whereby continuous sensory phenomena are perceived as distinct and separate percepts, is one of the most characteristic features of information processing in human cognition. CP is considered as the result of the integration of the top-down processing including background knowledge and verbal labeling and the bottom-up processing such as physical characteristics of the sensory signal. However, the underlying mechanisms governing the integration remain unclear. To address this issue, we focused on the temporal characteristics of CP of facial expression. In the current study, we investigated the contributions of temporal factors in CP processes, using facial expression recognition tasks as an example of CP. Participants completed an identification task and a discrimination task, well-established tasks for evaluating CP of facial expressions, with variable temporal parameters, that is, duration of stimulus presentation and delay time (interval between stimulus and response). The results demonstrated that the emotionally ambiguous stimuli are categorized more distinctively with the extension of delay length, not of stimulus duration. In contrast, the category boundary for facial expressions shifted toward "happy" with extention in stimulus duration, not in delay length. This dissociation between the impact of stimulus duration and delay suggests that there are two processes contributing to CP of facial emotion; one process may reflect the internal processing associated with the length of the delay period including verbal labeling of the stimuli, and the other process may reflect the temporal summation of stimulus inputs, associated with stimulus duration. These findings suggest that paying more attention to temporal factors in CP could be useful for further study of the mechanisms underlying CP.
| S-EPMC4521787 | biostudies-literature
Project description:IntroductionPsoriatic arthritis (PsA) is a chronic, inflammatory arthritis that affects an estimated 30% of patients with psoriasis. PsA is underdiagnosed in primary care and dermatology clinics due to a variety of reasons, including failure of healthcare providers to ask about symptoms, overlap of symptoms and signs with other rheumatologic conditions, and lack of a specific diagnostic test. A delay in PsA diagnosis and treatment, even as short as 6 months, can lead to decreased quality of life, increased joint damage, and worse long-term physical function. In this study, we sought to identify the clinical and genetic factors that help discriminate patients with PsA from those with cutaneous psoriasis only.MethodsWe analyzed a cohort of 974 psoriasis patients at an academic medical center, of whom 175 had confirmed PsA, and performed univariate, multivariate, and predictive modeling to determine factors associated with PsA.ResultsThe univariate analysis revealed significant positive associations of PsA with age, nail involvement, scalp involvement, skin fold involvement, elbow/knee involvement, psoriasis severity, plaque subtype, erythrodermic subtype, hypertension, type 2 diabetes, and coronary artery disease, and a significant negative association of PsA with the human leukocyte antigen (HLA)-C*06:02 allele. In the multivariate analysis, nail involvement, type 2 diabetes, and pustular psoriasis remained significantly associated with PsA, while HLA-C*06:02 positivity remained protective. There was a trend towards an association of PsA with older age, younger age of psoriasis onset, and skin fold involvement, while there was protective trend for smoking. A predictive model including both clinical and genetic factors showed reasonable discriminative ability between psoriasis and PsA, with an area under the curve of 0.87 for a receiver operating characteristic curve.ConclusionThis study identified a number of clinical and genetic features that could help stratify patients who are at higher risk for having PsA and for whom rheumatology referral may be beneficial.
| S-EPMC6261122 | biostudies-literature